AAI Public Affairs

The AAI public affairs program advocates on behalf of AAI members by identifying critically important issues in immunology and biomedical research, providing recommendations to relevant federal officials [including those at the National Institutes of Health (NIH)], and urging Congress and the Administration to increase funding for NIH and other key agencies/programs.

PUBLIC AFFAIRS NEWS
  • Congress Enacts Full Year Funding Bills for FY 2022
    President Joe Biden signed a fiscal year (FY) 2022 omnibus appropriations bill into law in March 2022 that includes full-year funding for all federal departments and agencies. Enactment of the bipartisan funding bill ended a drawn-out process that required four short-term funding bills, known as continuing resolutions (CRs), to keep the federal government open once the new fiscal year began on October 1, 2021. Read more »
  • President Biden Unveils Budget Request for FY 2023
    President Biden released his budget request for FY 2023 in late March. The president’s budget is an important statement of priorities that Congress takes into consideration when developing its own budget and appropriations bills. For FY 2023, the president recommends an extremely modest increase in the regular NIH budget of just $275 million (0.6%), less than the projected rate of biomedical research inflation (2.6%). Read more »
  • AAI Submits Congressional Testimony to Key Congressional Subcommittees
    CPA Chair Peter Jensen, M.D., recently submitted written testimony, on behalf of AAI, to the House and Senate Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittees, urging them to appropriate at least $49 billion (a $4 billion increase) for the NIH base budget to support its core operations in FY 2023. Read more »
  • AAI Urges Congressional Leaders to Appropriate Additional COVID-19 Relief Funding
    The Biden Administration is reportedly running out of funding for a wide range of activities crucial to controlling the COVID-19 pandemic, including diagnostic tests, monoclonal antibodies, antiviral drugs, and funds to continue crucial research. Read more »
  • AAI Public Policy Fellows Advocate for Increased NIH Funding During Virtual Capitol Hill Day
    In mid-March, the 2021-2022 AAI Public Policy Fellows participated in a two-day virtual Capitol Hill Day program. The Fellows, accompanied by CPA Chair Peter Jensen, M.D., AAI Advocacy Programs Subcommittee Chair Gretchen Diehl, Ph.D. (AAI ’14), AAI Director of Public Policy and Government Affairs Lauren Gross, J.D., and AAI Senior Manager of Science Policy and Legislative Affairs, met with a total of 26 congressional offices by video or phone. Read more »
  • CPA Hosts Timely Policy Sessions at IMMUNOLOGY 2022™
    The CPA sponsored two important and timely policy sessions at IMMUNOLOGY2022™, the AAI annual meeting that was held in Portland, Oregon, in early May. Both chaired by CPA Chair Peter Jensen, M.D., the sessions were: “ARPA-H: What You Need to Know and How it May Impact Federal Funding of Biomedical Research,” and “Vaccine Acceptance: Lessons from the Past and Tools for the Future.” Read more »

AAI Public Affairs Activities

Need Help Complying with the New NIH Data Management and Sharing (DMS) Policy? AAI Has Resources That Can Help

NIH has announced the implementation of its Data Management and Sharing (DMS) Policy, which requires that all applications submitted on or after January 25, 2023, include a DMS plan. AAI has developed two new resources to help immunologists draft DMS plans that comply with this new policy.

AAI Resources and Recommendations
for the NIH Data Management and Sharing Policy


AAI Guide to Developing Your NIH Data
Management and Sharing Plan

These resources were developed by the AAI Data Management and Sharing Working Group, established by the AAI Committee on Public Affairs. Please contact AAI Science Policy Analyst Emily Kansler, Ph.D., if you have any questions.


AAI Issues Statement Decrying Supreme Court Decision in Dobbs; Moves IMMUNOLOGY2024™ from Phoenix to Chicago

After carefully considering Arizona’s abortion law, which drastically restricts access to abortion services and related health care, and which went into effect after the U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, AAI has moved IMMUNOLOGY2024™ from Phoenix to Chicago. AAI is delighted to bring its annual scientific meeting back to Chicago for the first time since 1983.

In conjunction with this announcement, AAI issued a statement articulating its deep concern about the Dobbs decision’s deleterious impact.


AAI Issues Statement on Whether the COVID-19 Pandemic is Over

AAI Committee on Public Affairs Chair Peter Jensen, M.D., recently issued a statement responding to questions regarding whether the COVID-19 pandemic is over. The statement highlights the extraordinary progress that has been made in combatting COVID-19, including the rapid development of safe and effective vaccines. Jensen cautions, however, that “[w]hile remarkable progress has been made, hundreds of Americans are still dying from COVID-19 each day and millions are suffering from symptoms of Long COVID,” and urges all who are eligible “to get fully vaccinated and boosted.”


AAI Supports National Immunization Awareness Month

In recognition of National Immunization Awareness month, The American Association of Immunologists (AAI), the largest professional association of immunologists in the nation, reiterates its strong support of the use of vaccines to prevent disease.

© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
Phone: (301) 634-7178 | Fax: (301) 634-7887